Autonomix Medical, Inc. (AMIX) vs TransCode Therapeutics, Inc. (RNAZ)

A side-by-side comparison of Autonomix Medical, Inc. and TransCode Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Autonomix Medical, Inc. logo
AMIX
Autonomix Medical, Inc.
$2M
$3.53HealthcareDelayed quote: Oct 6, 2026, 2:47 PM EDT
TransCode Therapeutics, Inc. logo
RNAZ
TransCode Therapeutics, Inc.
$2M
$1.73HealthcareDelayed quote: Oct 6, 2026, 2:42 PM EDT

Total return — AMIX vs RNAZ

growth of $100 · dividends reinvested · last 3y
AMIX -99.8% (-88.2%/yr)RNAZ -99.7% (-84.9%/yr)RNAZ compounded faster over this window
050100150200Start $10020252026$0$0
AMIX RNAZ

AMIX vs RNAZ: by the numbers

  • •AMIX is the larger company ($2M vs $2M market cap).

Metrics side by side

Valuation

MetricAMIXRNAZ
P/B ratio0.61N/A

Profitability

MetricAMIXRNAZ
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-509.36%-30.92%
ROIC-518.15%-23.73%

Growth (annualized)

MetricAMIXRNAZ
Total return CAGR (5Y)N/A-93.39%

Go deeper

Full AMIX analysisFull RNAZ analysisInteractive comparison tool

Dig into the metrics

Autonomix Medical ROETransCode Therapeutics ROEAutonomix Medical operating marginTransCode Therapeutics operating marginAutonomix Medical revenue growthTransCode Therapeutics revenue growthAutonomix Medical free cash flowTransCode Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.